Leadership | Centerline Biomedical

Leadership

Centerline Biomedical Leadership Teams

Leadership Team

Board of Directors

Leadership Team

JIM DILLON

President and CEO

Mr. Dillon has over 30 years of experience in the innovation, development, and commercialization of cardiovascular devices. He is a proven leader and entrepreneur in structural heart & heart failure technologies to achieve novel patient care advancements. Over this multi-decade executive career, he has built global teams, created shareholder value, driven acquisitions and partnerships.

VIKASH GOEL, MS

Founder and CTO

Mr. Goel brings 15+ years of experience in medical device software/hardware design, specializing in the development of novel imaging, visualization, and analysis systems for vascular surgery. Working closely with surgeons, he developed a keen understanding of current clinical challenges and unmet needs, leading him to invent the IOPS® technology.

GREGORY R. MANN

Chief Financial Officer

Gregory W. Mann is a highly accomplished, results-driven senior financial and operations executive with more than 20 years of experience and a proven track record in finance, operations, raising capital, IPOs and mergers and acquisitions. He has served as CFO for multiple public and private medical device companies.

PAT CHUINARD

Vice President, Commercial Operations

Pat Chuinard has extensive experience in sales and marketing leadership. His career includes progressive leadership roles at Johnson & Johnson, Medtronic, St. Jude Medical, and Abiomed. He has expertise in leading high performance sales and marketing teams and successfully launching cutting-edge medical device technologies worldwide. Pat has a Bachelor of Science degree in Economics from the United States Military Academy at West Point, and an MBA from the University of Central Texas.

DENNIS KIRVEN

Vice President, Clinical Affairs

Dennis Kirven is an experienced clinical affairs executive with over 25 years of leadership experience in clinical research, field operations, and therapy development across the cardiovascular and structural heart device sectors. Prior to joining Centerline, Dennis served as Vice President of Clinical Affairs & Field Clinical Operations at BiVACOR, Inc. He previously held senior roles at BioVentrix, Inc., Abbott Laboratories (formerly St. Jude Medical), Abiomed, Infraredx, Datascope, and Medtronic. Dennis holds a Bachelor of Science in Circulation Technology from The Ohio State University and began his career as a Certified Clinical Perfusionist.

BRIAN WENZEL, PhD, MBA

VP of Research & Development

Dr. Wenzel is an accomplished leader with extensive experience in product design, development, and regulatory strategy within the medical device industry. Brian leverages his deep technical expertise and business acumen to bridge the gap between innovation and market success. Brian is known for his collaborative approach, guiding cross-functional teams to achieve challenging goals under stringent timelines. He holds a PhD in Biomedical Engineering and an MBA in Finance & Leadership.

TIM PEARSON

Director of Operations

Mr. Pearson brings 20+ years of global experience in Medical Device Operations and Supply Chain leadership, building on prior experience in the automotive and aerospace industries. Tim has fostered growth and operational excellence within multiple startup organizations as well as within large multinationals. Tim holds a MS degree in Industrial Engineering from Cleveland State University and an BSc in Mechanical Engineering from the University of Edinburgh.

KEVIN REED

Director of Quality & Regulatory Affairs

Mr. Reed has more than 25 years of medical device experience. His career includes several successful quality remediation activities as well as building robust teams that have delivered new products, improved reliability, and greater efficiency.

BRENT RUNKLE, PHR, SHRM-CP

Director, HR and Administration

Mr. Runkle brings 10+ years of strategic human resources experience, where he has led global HR initiatives across a variety of industries, most recently in laboratory instrumentation and medical device. Brent holds a Bachelors of Business Administration in Human Resource Management and Supply Chain/Operations Management from The University of Akron.

Scientific Advisory Board

Board of Directors

JIM DILLON

President and CEO

Mr. Dillon has over 30 years of experience in the innovation, development, and commercialization of cardiovascular devices. He is a proven leader and entrepreneur in structural heart & heart failure technologies to achieve novel patient care advancements. Over this multi-decade executive career, he has built global teams, created shareholder value, driven acquisitions and partnerships.

Arnaud Marie

General Manager for Global Interventional, GE Healthcare

Mr. Marie brings a breadth of experiences in Med Tech ranging from start-ups to large global business management. He has more than 26 years in the healthcare industry. As General Manager for GE Healthcare’s Imaging and Guiding Systems (IGS) business, he works with interventional cardiologists, radiologists, neuro radiologists and surgeons to innovate in the interventional field to help deliver better clinical and operational outcomes for both patients and providers.

Todd Schwarzinger

GM Business Development & Licensing, Cleveland Clinic Innovations

Mr. Schwarzinger brings over 20 years of innovation leadership, investment banking, investing and consulting experience in healthcare and life sciences. As General Manager of Business Development for Cleveland Clinic Innovations, he leads the business development and partnering efforts for Cleveland Clinic’s deep portfolio of innovative technologies.

Michael Whitman

CEO, Micro Interventional Devices Inc.

Mr. Whitman has over 40 years of experience in medical device design, manufacture and commercialization across cardiology, cardiovascular, and endovascular surgery specialties. He brings experience from both multinational corporate operations and start-ups to the board. A named inventor on over 100 US and foreign patents, he also founded two medical device companies (one NASDAQ-listed prior to acquisition). In his current role, he serves as chairman, founder and CEO of a structural heart company developing solutions for tricuspid and mitral disease.

MITCH WOLF

CEO, RIK Enterprises

Mr. Wolf has 25 years of experience in investment management across a broad variety of asset classes and industries, and also has extensive experience in business oversight and operations. In addition, Mr. Wolf has co-founded two successful business. He serves on the boards of several businesses and non-profits and is active in a number of Cleveland community-based charitable organizations.